New combo attack on tough liver cancer
NCT ID NCT06040099
Summary
This study is testing a three-part treatment for liver cancer that cannot be surgically removed. First, doctors deliver tiny radioactive beads directly to the tumor. Then, patients receive two immunotherapy drugs (durvalumab and bevacizumab) to help the immune system fight the cancer. The main goal is to see if this sequence can stop the cancer from growing for a longer time and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Aurora, Colorado, 80045, United States
-
Research Site
Gainesville, Florida, 32608, United States
-
Research Site
Orlando, Florida, 32804, United States
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Atlanta, Georgia, 30342, United States
-
Research Site
Chicago, Illinois, 60611, United States
-
Research Site
Boston, Massachusetts, 02118, United States
-
Research Site
Detroit, Michigan, 48201, United States
-
Research Site
St Louis, Missouri, 63110, United States
-
Research Site
Trenton, New Jersey, 08690, United States
-
Research Site
Buffalo, New York, 14263, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
Chapel Hill, North Carolina, 27599, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Portland, Oregon, 97239, United States
-
Research Site
Philadelphia, Pennsylvania, 19107, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Charlottesville, Virginia, 22908, United States
-
Research Site
Seattle, Washington, 98195, United States
-
Research Site
Milwaukee, Wisconsin, 53215, United States
-
Research Site
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.